433 related articles for article (PubMed ID: 28238733)
1. Fragmentation of the CRISPR-Cas Type I-B signature protein Cas8b.
Richter H; Rompf J; Wiegel J; Rau K; Randau L
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):2993-3000. PubMed ID: 28238733
[TBL] [Abstract][Full Text] [Related]
2. Characterization of CRISPR RNA processing in Clostridium thermocellum and Methanococcus maripaludis.
Richter H; Zoephel J; Schermuly J; Maticzka D; Backofen R; Randau L
Nucleic Acids Res; 2012 Oct; 40(19):9887-96. PubMed ID: 22879377
[TBL] [Abstract][Full Text] [Related]
3. Modulating the Cascade architecture of a minimal Type I-F CRISPR-Cas system.
Gleditzsch D; Müller-Esparza H; Pausch P; Sharma K; Dwarakanath S; Urlaub H; Bange G; Randau L
Nucleic Acids Res; 2016 Jul; 44(12):5872-82. PubMed ID: 27216815
[TBL] [Abstract][Full Text] [Related]
4. Cross-cleavage activity of Cas6b in crRNA processing of two different CRISPR-Cas systems in Methanosarcina mazei Gö1.
Nickel L; Ulbricht A; Alkhnbashi OS; Förstner KU; Cassidy L; Weidenbach K; Backofen R; Schmitz RA
RNA Biol; 2019 Apr; 16(4):492-503. PubMed ID: 30153081
[TBL] [Abstract][Full Text] [Related]
5. A complex of Cas proteins 5, 6, and 7 is required for the biogenesis and stability of clustered regularly interspaced short palindromic repeats (crispr)-derived rnas (crrnas) in Haloferax volcanii.
Brendel J; Stoll B; Lange SJ; Sharma K; Lenz C; Stachler AE; Maier LK; Richter H; Nickel L; Schmitz RA; Randau L; Allers T; Urlaub H; Backofen R; Marchfelder A
J Biol Chem; 2014 Mar; 289(10):7164-7177. PubMed ID: 24459147
[TBL] [Abstract][Full Text] [Related]
6. In vitro assembly and activity of an archaeal CRISPR-Cas type I-A Cascade interference complex.
Plagens A; Tripp V; Daume M; Sharma K; Klingl A; Hrle A; Conti E; Urlaub H; Randau L
Nucleic Acids Res; 2014 Apr; 42(8):5125-38. PubMed ID: 24500198
[TBL] [Abstract][Full Text] [Related]
7. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis ofCas6b processing and CRISPR RNA stability.
Richter H; Lange SJ; Backofen R; Randau L
RNA Biol; 2013 May; 10(5):700-7. PubMed ID: 23392318
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
Osawa T; Inanaga H; Sato C; Numata T
Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
[TBL] [Abstract][Full Text] [Related]
10. Approaches to study CRISPR RNA biogenesis and the key players involved.
Behler J; Hess WR
Methods; 2020 Feb; 172():12-26. PubMed ID: 31325492
[TBL] [Abstract][Full Text] [Related]
11. Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.
Peng W; Li H; Hallstrøm S; Peng N; Liang YX; She Q
RNA Biol; 2013 May; 10(5):738-48. PubMed ID: 23392249
[TBL] [Abstract][Full Text] [Related]
12. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family.
Hrle A; Maier LK; Sharma K; Ebert J; Basquin C; Urlaub H; Marchfelder A; Conti E
RNA Biol; 2014; 11(8):1072-82. PubMed ID: 25483036
[TBL] [Abstract][Full Text] [Related]
13. Essential requirements for the detection and degradation of invaders by the Haloferax volcanii CRISPR/Cas system I-B.
Maier LK; Lange SJ; Stoll B; Haas KA; Fischer S; Fischer E; Duchardt-Ferner E; Wöhnert J; Backofen R; Marchfelder A
RNA Biol; 2013 May; 10(5):865-74. PubMed ID: 23594992
[TBL] [Abstract][Full Text] [Related]
14. Substrate generation for endonucleases of CRISPR/cas systems.
Zoephel J; Dwarakanath S; Richter H; Plagens A; Randau L
J Vis Exp; 2012 Sep; (67):. PubMed ID: 22986408
[TBL] [Abstract][Full Text] [Related]
15. Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex.
Majumdar S; Ligon M; Skinner WC; Terns RM; Terns MP
Extremophiles; 2017 Jan; 21(1):95-107. PubMed ID: 27582008
[TBL] [Abstract][Full Text] [Related]
16. An active immune defense with a minimal CRISPR (clustered regularly interspaced short palindromic repeats) RNA and without the Cas6 protein.
Maier LK; Stachler AE; Saunders SJ; Backofen R; Marchfelder A
J Biol Chem; 2015 Feb; 290(7):4192-201. PubMed ID: 25512373
[TBL] [Abstract][Full Text] [Related]
17. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
Takeshita D; Sato M; Inanaga H; Numata T
J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex.
Numata T; Inanaga H; Sato C; Osawa T
J Mol Biol; 2015 Jan; 427(2):259-73. PubMed ID: 25451598
[TBL] [Abstract][Full Text] [Related]
19. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
[TBL] [Abstract][Full Text] [Related]
20. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) RNAs in the Porphyromonas gingivalis CRISPR-Cas I-C System.
Burmistrz M; Rodriguez Martinez JI; Krochmal D; Staniec D; Pyrc K
J Bacteriol; 2017 Dec; 199(23):. PubMed ID: 28893837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
